Brain Protein Loss May Drive Aging—And Restoring It Reverses Decline in Mice

A Protein Called Menin May Be Central to Aging

Scientists have identified a potentially major mechanism linking brain chemistry to aging throughout the body. Researchers at Xiamen University discovered that a protein called Menin, located in the hypothalamus deep within the brain, gradually declines with age and may drive several hallmark signs of aging. The hypothalamus, a small region near the brain's base, regulates temperature, hunger, metabolism, sleep, and hormones—systems that touch nearly every organ. When Menin levels drop, inflammation builds up in the brain, and this appears to trigger physical and cognitive decline across the body.

The team created genetically modified mice with reduced Menin and observed accelerated aging: thinner skin, reduced bone mass, worse memory and balance, and modestly shortened lifespans. Critically, these changes did not simply accompany aging—they appeared to be actively driven by Menin loss. This finding suggested that if scientists could restore Menin, they might reverse some damage.

Restoring Menin Produced Rapid, Measurable Improvements

When researchers used gene delivery to increase Menin production in the ventromedial hypothalamus of older 20-month-old mice, the results were striking. Within just 30 days, treated animals showed significant improvements: thicker skin, increased bone mass, enhanced learning and memory, better balance, and reduced brain inflammation. These mice also lived longer than untreated controls. The speed of improvement—visible changes in under a month—was surprising and suggested that at least some aging effects are not irreversible but rather driven by active biological processes that can be modified.

An Amino Acid Revealed Part of the Mechanism

The researchers uncovered an intriguing clue about how Menin produces these effects. When Menin declined, so did levels of D-serine, a specialized amino acid that regulates NMDA receptors on neurons—proteins crucial for communication between brain cells and for learning and memory formation. Menin controls production of an enzyme (PHGDH) involved in generating D-serine. When the team gave older mice D-serine supplements in drinking water for just three weeks, their performance on memory and learning tests improved significantly.

However, D-serine supplementation had an important limitation: it improved cognition but did not restore lost bone mass or skin thickness like Menin restoration did. This suggests Menin influences aging through multiple biological pathways, with D-serine accounting for only part of its protective effects.

Broader Research Confirms Brain's Control Over Aging

Since the original 2023 findings, subsequent research has strengthened the connection between the hypothalamus and aging. A 2024 study from Washington University identified different hypothalamic neurons that communicate with fat tissue, and stimulating this pathway increased physical activity, improved metabolism, and extended lifespan in mice. A detailed 2025 analysis of 1.2 million mouse brain cells in Nature found that cells around the hypothalamus were particularly vulnerable to aging, with reduced activity in genes supporting normal function and increased activity in inflammatory genes.

Research published in 2026 has further validated the theme. One study found that strengthening daily biological rhythms in specific hypothalamic regions improved aging measurements and extended lifespan in male mice. Another identified a protein called Mimecan that helps muscles communicate with the hypothalamus and brown fat, and restoring it in older mice improved this communication and longevity. These discoveries paint aging not as controlled by a single "master switch" but as involving complex, coordinated communication between the brain and body through multiple neural circuits, hormones, and metabolic signals.

Potential Human Applications Face Hurdles

While the mouse studies are compelling, translating these findings to humans requires caution. A small 2016 clinical trial testing D-serine in 50 healthy older adults showed modest benefits—participants improved on one spatial learning test but showed no significant gains on other cognitive measures or mood assessments. More recent research suggests D-serine's effects depend heavily on specific biological circumstances, implying that blanket supplementation may not help everyone. The path from laboratory mouse to human treatment remains long, and unlike the controlled genetic interventions in mice, safely and effectively restoring Menin or other proteins in the human brain poses substantial technical and regulatory challenges.